Related Experiment Videos

Laser therapy for retinopathy of prematurity

M W Preslan1

  • 1Department of Ophthalmology, University of Maryland, Baltimore 21201.

Journal of Pediatric Ophthalmology and Strabismus
|March 1, 1993
PubMed

Insights

Indirect ophthalmoscope argon laser photocoagulation effectively treated threshold retinopathy of prematurity (ROP) in nine infants. This laser treatment offers a promising alternative for managing high-risk ROP cases.

Area of Science:

  • Ophthalmology
  • Neonatal Medicine
  • Medical Technology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Threshold ROP requires timely intervention to prevent severe visual loss.
  • Previous treatments have varied in efficacy and potential side effects.

Purpose of the Study:

  • To evaluate the efficacy of indirect ophthalmoscope argon laser photocoagulation for threshold retinopathy of prematurity (ROP).
  • To assess the outcomes and follow-up results of this laser treatment in affected infants.

Main Methods:

  • Nine patients with threshold ROP were treated.
  • A total of 16 eyes underwent indirect ophthalmoscope argon laser photocoagulation.
  • Treatment was administered at an average postconceptional age of 36.31 weeks.

Main Results:

  • All treated eyes demonstrated regression of threshold ROP.
  • Postoperative follow-up ranged from 1 to 14 months.
  • No major complications were reported during the follow-up period.

Conclusions:

  • Indirect ophthalmoscope argon laser photocoagulation is an effective treatment for threshold retinopathy of prematurity.
  • This method represents a viable alternative for managing high-risk ROP.
  • Further studies can explore long-term outcomes and compare with other ROP interventions.

Related Concept Videos